Systemic Sclerosis (SSc) trials recruiting in North Carolina

Fewer than 3 recruiting trials found.

All Systemic Sclerosis (SSc) trials nationally

Cities in North Carolina

Recruiting trials in North Carolina

• A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
  NCT06308978 · Phase: Phase 1 · Ages: 12 Years to 70 Years · Sex: All (male and female) · North Carolina: Durham
• AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
  NCT06991114 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Charlotte, Statesville